IFRX InflaRx N.V.
Healthcare$2.61+5.67%ClosedMarket Cap: $188.7M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$5.50
Target (Median)
$5.50
Target Range
$2.00 - $9.00
Upside from current price: 110.7%
Rating Distribution
1 Strong Buy6 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Raymond James | upgrade | Strong Buy | Outperform |
| 2026-05-11 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-21 | Guggenheim | maintain | Buy | Buy |
| 2026-03-20 | Guggenheim | maintain | Buy | Buy |
| 2025-12-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-12-03 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2025-11-10 | Guggenheim | maintain | Buy | Buy |
| 2025-05-29 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.44 | $16.4K | 4 |
| Sun Dec 31 | $-0.43 | $11.8K | 3 |
| Mon Dec 31 | $-0.50 | $19.2K | 2 |
| Tue Dec 31 | $-0.46 | $47.3M | 2 |